It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASTH’s FA Score shows that 0 FA rating(s) are green whileLTGHY’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASTH’s TA Score shows that 4 TA indicator(s) are bullish while LTGHY’s TA Score has 4 bullish TA indicator(s).
ASTH (@Medical/Nursing Services) experienced а -29.48% price change this week, while LTGHY (@Medical/Nursing Services) price change was -1.53% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.23%. For the same industry, the average monthly price growth was +0.62%, and the average quarterly price growth was +1650.69%.
ASTH is expected to report earnings on Feb 20, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
ASTH | LTGHY | ASTH / LTGHY | |
Capitalization | 1.88B | 1.7B | 111% |
EBITDA | 124M | 3.3B | 4% |
Gain YTD | 9.530 | 49.107 | 19% |
P/E Ratio | 32.55 | 20.04 | 162% |
Revenue | 1.39B | 30B | 5% |
Total Cash | 296M | N/A | - |
Total Debt | 321M | N/A | - |
ASTH | LTGHY | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 53 | 82 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 69 | 100 | |
SMR RATING 1..100 | 65 | 96 | |
PRICE GROWTH RATING 1..100 | 61 | 40 | |
P/E GROWTH RATING 1..100 | 85 | 80 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LTGHY's Valuation (15) in the null industry is somewhat better than the same rating for ASTH (68). This means that LTGHY’s stock grew somewhat faster than ASTH’s over the last 12 months.
ASTH's Profit vs Risk Rating (69) in the null industry is in the same range as LTGHY (100). This means that ASTH’s stock grew similarly to LTGHY’s over the last 12 months.
ASTH's SMR Rating (65) in the null industry is in the same range as LTGHY (96). This means that ASTH’s stock grew similarly to LTGHY’s over the last 12 months.
LTGHY's Price Growth Rating (40) in the null industry is in the same range as ASTH (61). This means that LTGHY’s stock grew similarly to ASTH’s over the last 12 months.
LTGHY's P/E Growth Rating (80) in the null industry is in the same range as ASTH (85). This means that LTGHY’s stock grew similarly to ASTH’s over the last 12 months.
ASTH | LTGHY | |
---|---|---|
RSI ODDS (%) | 2 days ago63% | N/A |
Stochastic ODDS (%) | 2 days ago76% | 2 days ago70% |
Momentum ODDS (%) | 2 days ago72% | 2 days ago75% |
MACD ODDS (%) | 2 days ago72% | N/A |
TrendWeek ODDS (%) | 2 days ago73% | 2 days ago71% |
TrendMonth ODDS (%) | 2 days ago75% | 2 days ago70% |
Advances ODDS (%) | 9 days ago79% | 7 days ago70% |
Declines ODDS (%) | 2 days ago71% | 2 days ago61% |
BollingerBands ODDS (%) | 2 days ago71% | 2 days ago84% |
Aroon ODDS (%) | 2 days ago81% | 2 days ago71% |
A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with AMN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then AMN could also see price increases.
Ticker / NAME | Correlation To ASTH | 1D Price Change % | ||
---|---|---|---|---|
ASTH | 100% | -2.24% | ||
AMN - ASTH | 49% Loosely correlated | -5.71% | ||
CCRN - ASTH | 47% Loosely correlated | -8.43% | ||
USPH - ASTH | 39% Loosely correlated | -0.25% | ||
AVAH - ASTH | 38% Loosely correlated | -0.86% | ||
SGRY - ASTH | 35% Loosely correlated | -13.75% | ||
More |
A.I.dvisor tells us that LTGHY and ASTH have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LTGHY and ASTH's prices will move in lockstep.
Ticker / NAME | Correlation To LTGHY | 1D Price Change % | ||
---|---|---|---|---|
LTGHY | 100% | -2.03% | ||
ASTH - LTGHY | 20% Poorly correlated | -2.24% | ||
LWSCF - LTGHY | 16% Poorly correlated | N/A | ||
HLYK - LTGHY | 4% Poorly correlated | +5.26% | ||
JRSS - LTGHY | 3% Poorly correlated | N/A | ||
NVLPF - LTGHY | 2% Poorly correlated | -7.65% | ||
More |